Cor.Con. International

CPHI Pharma Awards 2026

Epilamba Junior shortlisted for the CPHI Pharma Awards 2026

International Road Map 2026

What a 2026 for Cor.Con. International and its International Road Map!

Co-morbidities in epilepsy, the impact on children’s lives

Comorbidities in childhood epilepsy are numerous and complex. The co-morbidities of epilepsy do not only affect the cognitive and emotional spheres, but also have a direct impact on the child’s quality of life and global development.

Epilamba Junior

Epilamba Junior is a food supplement for the management of comorbidities in anti-epileptic drug therapy. Effective on brain and gastrointestinal functions.

Homocysteine

High homocysteine: what it is, why it happens and how to lower it

Cogiton

Cogiton is a patented food supplement based on a specific
and harmonized combination of ingredients
sustaining the normal function of the nervous system

Menopause

Menopause: what it is, how to recognise the initial signs and relief from symptoms

Afragil

Afragil is a food supplement for the gynecological health. Effective on oxidative stress and menopause symptoms

Company

We are a private Italian company that daily researches and develops innovative solutions to wellness problems. We believe that people can live longer and healthier lives.

Learn more

Products

We develop evidence-based food supplements and cosmeceuticals, from scientific rationale to market, through research, scientific publications, patenting and production.

Learn more

Services

We work at your side in order to create original health-oriented products with innovative and customized formulas, dictated by market and by your requirements.

Learn more

Product Highlight

A Dedicated Line for GLP-1 RA Users

Three specific formulations, designed to accompany every phase of the therapeutic journey: from the start of treatment through its maintenance, to the delicate phase following discontinuation.

  • EuSide— Digestive comfort and energy
  • EuPower — Muscle tone and mass
  • EuStabil— Stability after discontinuation

News and Articles

Nutritional support for those undergoing GLP-1 agonist therapy

Discover our new line of three complementary food supplements designed to provide targeted nutritional support throughout the GLP 1 therapeutic journey, from the initial stages and treatment maintenance to the period following discontinuation.

Cor.Con. International at PharmaSynergyOTC 2026 in Rome

The event provided an excellent opportunity to meet current and potential partners, explore new business opportunities and discuss future collaborations across international markets.

As Cor.Con. International continues to expand its international footprint, face-to-face meetings remain an important part of our approach to building strong, long-term partnerships and developing new opportunities in the healthcare sector.

Epilamba Junior shortlisted for the CPHI Pharma Awards 2026

Epilamba Junior by Cor.Con. International has been shortlisted as a finalist for the CPHI Pharma Awards 2026 in the Finished Formulation category.

Read the article
Logos